The disclosure generally relates to compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds are ligands of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.
申请公布号
CA2936293(A1)
申请公布日期
2015.07.16
申请号
CA20152936293
申请日期
2015.01.06
申请人
BRISTOL-MYERS SQUIBB COMPANY
发明人
KING, DALTON;THOMPSON, LORIN A., III;SHI, JIANLIANG;THANGATHIRUPATHY, SRINIVASAN;WARRIER, JAYAKUMAR SANKARA;ISLAM, IMADUL;MACOR, JOHN E.